These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6366073)

  • 1. Experimental bullous pemphigoid in guinea pigs: the role of pemphigoid antibodies, complement, and migrating cells.
    Naito K; Morioka S; Ikeda S; Ogawa H
    J Invest Dermatol; 1984 Mar; 82(3):227-30. PubMed ID: 6366073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of specific histologic changes in guinea pig skin treated with bullous pemphigoid antibodies.
    Gammon WR; Briggaman RA
    J Invest Dermatol; 1988 Apr; 90(4):495-500. PubMed ID: 3280699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenic mechanisms of blister formation in bullous pemphigoid.
    Naito K; Morioka S; Ogawa H
    J Invest Dermatol; 1982 Nov; 79(5):303-6. PubMed ID: 6752292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement system in bullous pemphigoid: VII. Fixation of the regulatory protein beta 1H globulin by pemphigoid antibody.
    Lee CW; Jordon RE
    J Invest Dermatol; 1980 Dec; 75(6):465-9. PubMed ID: 6449528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid.
    Yamamoto K; Inoue N; Masuda R; Fujimori A; Saito T; Imajoh-Ohmi S; Shinkai H; Sakiyama H
    J Invest Dermatol; 2002 Mar; 118(3):485-92. PubMed ID: 11874488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.
    Gammon WR; Lewis DM; Carlo JR; Sams WM; Wheeler CE
    J Invest Dermatol; 1980 Oct; 75(4):334-9. PubMed ID: 7000926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathologic mechanisms in pemphigus and bullous pemphigoid.
    Jordon RE; Kawana S; Fritz KA
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):72s-78s. PubMed ID: 3891883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
    Brooks WS; Lee YY; Abell E; Deng JS
    J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo J
    J Invest Dermatol; 1981 Jun; 76(6):514-22. PubMed ID: 7017015
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement.
    Iwatsuki K; Tagami H; Yamada M
    Acta Derm Venereol; 1983; 63(4):290-5. PubMed ID: 6195859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deposition of the membrane attack complex of complement in bullous pemphigoid.
    Dahl MV; Falk RJ; Carpenter R; Michael AF
    J Invest Dermatol; 1984 Feb; 82(2):132-5. PubMed ID: 6363566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
    Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
    J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
    Gammon WR; Inman AO; Wheeler CE
    J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
    Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
    J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complement system in bullous and cicatricial pemphigoid].
    Mashkilleĭson AL; Golousenko IIu
    Vestn Dermatol Venerol; 1984 Jan; (1):14-7. PubMed ID: 6367260
    [No Abstract]   [Full Text] [Related]  

  • 17. The complement fixing ability of anti-basement membrane zone IgG subclass of herpes gestationis and bullous pemphigoid.
    Suzuki M; Watanabe C; Yaoita H
    Acta Derm Venereol; 1989; 69(1):6-11. PubMed ID: 2563610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid.
    Messingham KN; Wang JW; Holahan HM; Srikantha R; Aust SC; Fairley JA
    Exp Dermatol; 2016 Jan; 25(1):50-5. PubMed ID: 26475989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized chronic pemphigoid of Brunsting-Perry. Ultrastructural localization of IgG and complement components.
    Murata Y; Tani M; Kumano K
    Arch Dermatol; 1983 Nov; 119(11):921-4. PubMed ID: 6357105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.